These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 37492490)

  • 41. Heterogeneity in the respiratory symptoms of patients with mild-to-moderate COPD.
    Johnson KM; Safari A; Tan WC; Bourbeau J; FitzGerald JM; Sadatsafavi M; Study OBOTCCOOLDC;
    Int J Chron Obstruct Pulmon Dis; 2018; 13():3983-3995. PubMed ID: 30587954
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The value of telehealth in the early detection of chronic obstructive pulmonary disease exacerbations: A prospective observational study.
    Hamad GA; Crooks M; Morice AH
    Health Informatics J; 2016 Jun; 22(2):406-13. PubMed ID: 25564494
    [TBL] [Abstract][Full Text] [Related]  

  • 43. "Frequent exacerbator" is a phenotype of poor prognosis in Japanese patients with chronic obstructive pulmonary disease.
    Tomioka R; Kawayama T; Suetomo M; Kinoshita T; Tokunaga Y; Imaoka H; Matsunaga K; Okamoto M; Hoshino T
    Int J Chron Obstruct Pulmon Dis; 2016; 11():207-16. PubMed ID: 26893552
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Defining Chronic Mucus Hypersecretion Using the CAT in the SPIROMICS Cohort.
    Stott-Miller M; Müllerová H; Miller B; Tabberer M; El Baou C; Keeley T; Martinez FJ; Han M; Dransfield M; Hansel NN; Cooper CB; Woodruff P; Ortega VE; Comellas AP; Paine Iii R; Kanner RE; Anderson W; Drummond MB; Kim V; Tal-Singer R; Lazaar AL
    Int J Chron Obstruct Pulmon Dis; 2020; 15():2467-2476. PubMed ID: 33116463
    [TBL] [Abstract][Full Text] [Related]  

  • 45. COPD exacerbations by disease severity in England.
    Merinopoulou E; Raluy-Callado M; Ramagopalan S; MacLachlan S; Khalid JM
    Int J Chron Obstruct Pulmon Dis; 2016; 11():697-709. PubMed ID: 27099486
    [TBL] [Abstract][Full Text] [Related]  

  • 46. No association between exacerbation frequency and stroke in patients with COPD.
    Windsor C; Herrett E; Smeeth L; Quint JK
    Int J Chron Obstruct Pulmon Dis; 2016; 11():217-25. PubMed ID: 26893553
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A study to assess COPD Symptom-based Management and to Optimise treatment Strategy in Japan (COSMOS-J) based on GOLD 2011.
    Betsuyaku T; Kato M; Fujimoto K; Hagan G; Kobayashi A; Hitosugi H; James M; Jones PW
    Int J Chron Obstruct Pulmon Dis; 2013; 8():453-9. PubMed ID: 24124358
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Exacerbations and lung function decline in COPD: new insights in current and ex-smokers.
    Makris D; Moschandreas J; Damianaki A; Ntaoukakis E; Siafakas NM; Milic Emili J; Tzanakis N
    Respir Med; 2007 Jun; 101(6):1305-12. PubMed ID: 17112715
    [TBL] [Abstract][Full Text] [Related]  

  • 49. BODE index and GOLD staging as predictors of 1-year exacerbation risk in chronic obstructive pulmonary disease.
    Faganello MM; Tanni SE; Sanchez FF; Pelegrino NR; Lucheta PA; Godoy I
    Am J Med Sci; 2010 Jan; 339(1):10-4. PubMed ID: 19926966
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy of Low-Dose versus High-Dose Continuous Cyclic Azithromycin Therapy for Preventing Acute Exacerbations of COPD.
    Pomares X; Montón C; Huertas D; Marín A; Cuevas E; Casabella A; Martí S; Oliva JC; Santos S
    Respiration; 2021; 100(11):1070-1077. PubMed ID: 34365450
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Resting Borg score as a predictor of safe discharge of chronic obstructive pulmonary disease from the emergency department observation unit.
    Sengupta R; Loftus TM; Doers M; Jandarov RA; Phillips M; Ko J; Panos RJ; Zafar MA
    Acad Emerg Med; 2020 Dec; 27(12):1302-1311. PubMed ID: 32678934
    [TBL] [Abstract][Full Text] [Related]  

  • 52. CAT Score and SGRQ Definitions of Chronic Bronchitis as an Alternative to the Classical Definition.
    Choi JY; Yoon HK; Shin KC; Park SY; Lee CY; Ra SW; Jung KS; Yoo KH; Lee CH; Rhee CK
    Int J Chron Obstruct Pulmon Dis; 2019; 14():3043-3052. PubMed ID: 31920301
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Relationship between respiratory symptoms and medical treatment in exacerbations of COPD.
    Calverley P; Pauwels Dagger R; Löfdahl CG; Svensson K; Higenbottam T; Carlsson LG; Ståhl E
    Eur Respir J; 2005 Sep; 26(3):406-13. PubMed ID: 16135720
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pneumonia as comorbidity in chronic obstructive pulmonary disease (COPD). Differences between acute exacerbation of COPD and pneumonia in patients with COPD.
    Boixeda R; Bacca S; Elias L; Capdevila JA; Vilà X; Mauri M; Almirall J
    Arch Bronconeumol; 2014 Dec; 50(12):514-20. PubMed ID: 25443591
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impact of mild exacerbation on COPD symptoms in a Japanese cohort.
    Sato M; Chubachi S; Sasaki M; Haraguchi M; Kameyama N; Tsutsumi A; Takahashi S; Nakamura H; Asano K; Betsuyaku T
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1269-78. PubMed ID: 27354785
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Healthcare, Medication Utilization and Outcomes of Patients with COPD by GOLD Classification in England.
    Sansbury LB; Rothnie KJ; Bains C; Compton C; Anley G; Ismaila AS
    Int J Chron Obstruct Pulmon Dis; 2021; 16():2591-2604. PubMed ID: 34552325
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The impact of impaired sleep quality on symptom change and future exacerbation of chronic obstructive pulmonary disease.
    Lin L; Song Q; Duan J; Liu C; Cheng W; Zhou A; Peng Y; Zhou Z; Zeng Y; Chen Y; Cai S; Chen P
    Respir Res; 2023 Mar; 24(1):98. PubMed ID: 36998013
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Home monitoring of breathing rate in people with chronic obstructive pulmonary disease: observational study of feasibility, acceptability, and change after exacerbation.
    Rubio N; Parker RA; Drost EM; Pinnock H; Weir CJ; Hanley J; Mantoani LC; MacNee W; McKinstry B; Rabinovich RA
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1221-1231. PubMed ID: 28458534
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Alterations in circulating mitochondrial signals at hospital admission for COPD exacerbation.
    Amado CA; Martín-Audera P; Agüero J; Ferrer-Pargada D; Josa Laorden B; Boucle D; Berja A; Lavín BA; Guerra AR; Ghadban C; Muñoz P; García-Unzueta M
    Chron Respir Dis; 2023; 20():14799731231220058. PubMed ID: 38112134
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Validation of ACCESS: an automated tool to support self-management of COPD exacerbations.
    Boer LM; van der Heijden M; van Kuijk NM; Lucas PJ; Vercoulen JH; Assendelft WJ; Bischoff EW; Schermer TR
    Int J Chron Obstruct Pulmon Dis; 2018; 13():3255-3267. PubMed ID: 30349231
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.